EUVIMEDAtrasti EUVIMED
EUVIMED · CrossrefJournal

Blood Neoplasia

ISSN 2950-3280 · Elsevier BV

Latest articles

  1. Increased severe neurotoxicity and hospital stay in octogenarians receiving CAR T-cell therapy for large B-cell lymphoma

    Dasom Lee, Masooma S. Rana, Alexandria Jensen, Edna Cheung, Nima Ghalehsari, William Wang, Eric Heng, Humza Khan, Bita Sahaf, Jayasindhu Mallampet, Sheila Lahijani, Faisal Cheema, Lauren S. Maeda, Connie Chen, Lekha Mikkilineni, Surbhi Sidana, Melody Smith, Wen-Kai Weng, Sushma Bharadwaj, Matthew J. Frank, David B. Miklos, Saurabh Dahiya

    Published: 2026-11DOI: 10.1016/j.bneo.2026.100297

  2. Circulating Multiple Myeloma Cell Kinetics and Genomic Profiling Predict Resistance to Targeted Immunotherapies

    Binod Dhakal, Michael Slade, Alberto Ferrarini, Paola Tononi, Marla Ruzicka, Aniko Szabo, Othman Akhtar, Jasper Olsem, Ravi Narra, Mark Schroeder, Hima Bansal, Maria Jose Acevedo-Calado, Oren Pasvolsky, Mahmoud R. Gaballa, Khanmi Kasomva, Melody R. Becnel, Donna M. Weber, Krina K. Patel, Sheeba K. Thomas, J Christine Ye, Meera Mohan, Fumou Sun, Zoltan Simandi, Sabari Radhakrishnan, Keith Stockert-Goldtsein, Wojciech Swat, Frank Kuhr, Ravi Vij, Federica Sola, Giuseppe Giacomo Montefrancesco, Marianna Garonzi, Nicolò Manaresi, Anita D’Souza, Robert Z Orlowski, Hans C. Lee

    Published: 2026-11DOI: 10.1016/j.bneo.2026.100332

  3. Post-transplant outcomes after intensive chemotherapy versus hypomethylating agent/venetoclax in acute myeloid leukemia

    John Preston Claiborne, Venkata Preetam Sandeep Kaduluri, Hua-Ling Tsai, Gabriel Ghiaur, Ivana Gojo, Amy E. DeZern, B. Douglas Smith, Tania Jain, Gabrielle T. Prince, Javier Bolaños-Meade, Ephraim Fuchs, Philip H. Imus, Lukasz P. Gondek, William Brian Dalton, Theodoros Karantanos, Ravi Varadhan, Mark J. Levis, Richard J. Jones, Jonathan A. Webster, Alexander J. Ambinder

    Published: 2026-11DOI: 10.1016/j.bneo.2026.100338

  4. Prospective Analyses of the Utility of Liquid Biopsy in Patients with Fever of Unknown Origin Suspected of Lymphoma

    Akinao Okamoto, Masashi Sanada, Takahiko Yasuda, Seiichi Kato, Akira Satou, Takuma Ishihara, Kosei Matsue, Hiroki Hosoi, Masahiro Yoshida, Satsuki Murakami, Eisei Kondo, Yasufumi Masaki, Yasuhiro Suzuki, Kana Miyazaki, Tomohiro Kajiguchi, Junji Hiraga, Shingo Kurahashi, Yuichiro Inagaki, Kazutaka Ozeki, Shigeki Saito, Toshiki Terao, Sachiko Iba, Keiko Hattori, Hideyuki Yamamoto, Naoe Goto, Chisako Iriyama, Masataka Okamoto, Akihiro Tomita

    Published: 2026-10DOI: 10.1016/j.bneo.2026.100321

  5. Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma

    Alexander D. Sanjurjo, David DeStephano, Justine Kahn, Melissa Beauchemin, Caitlin Gribbin, Rajbir Toor, Jia Ruan, Kelly Meza, Eduardo Edelman Saul, Bryan Valcarcel, Luis Malpica, Kimberly Seymour, Nicholas Li, R. Alejandro Sica, Rahul Nayak, Pamela Allen, Meghana Subramanian, Yun Kyoung Tiger, Alexandra Lyubimova, Leily Santos-Carrion, Carla Romagnoli, Jacqueline Barrientos, Miguel Ruiz, Jonathan Brammer, Haris Qureshi, Francine Foss, Tarsheen Sethi, Omar Elghawy, Stefan Barta, Can Jones, Jose Sandoval-Sus, Hua-Jay J. Cherng, Barbara Pro, Jennifer E. Amengual, Seda S. Tolu

    Published: 2026-10DOI: 10.1016/j.bneo.2026.100328

  6. Ten-day decitabine vs “3+7” in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21

    Michael Lübbert, Pierre W. Wijermans, Michal Kicinski, Sylvain Chantepie, Walter J. F. M. Van der Velden, Richard Noppeney, Laimonas Griškevičius, Andreas Neubauer, Martina Crysandt, Radovan Vrhovac, Mario Luppi, Stephan Fuhrmann, Ernesta Audisio, Anna Candoni, Olivier Legrand, Robin Foà, Gianluca Gaidano, Danielle van Lammeren-Venema, Eduardus F. M. Posthuma, Mels Hoogendoorn, Anne Giraut, Stephanie Antunes, Marian Stevens-Kroef, Joop H. Jansen, Aniek O. de Graaf, Fabio Efficace, Emanuele Ammatuna, Quentin Levesque, Ralph Wäsch, Heiko Becker, Nicole Blijlevens, Ulrich Dührsen, Frédéric Baron, Stefan Suciu, Adriano Venditti, Gerwin Huls

    Published: 2026-08DOI: 10.1016/j.bneo.2026.100246

Volumes

2026 · 1582025 · 1232024 · 46

Jūsų darbui tinkamos žinios.

Nuo nemokamos pradžios ir asmeninės literatūros paieškos iki viso Research Suite.

Peržiūrėti tarifus →

Ar įtraukti visi leidėjų pilnieji tekstai?

Ne. Bibliografiniai įrašai, santraukos ir pilnieji tekstai yra skirtingas turinys. Ar pilnasis tekstas prieinamas, priklauso nuo šaltinio, Open Access ir jūsų turimų licencijų. EUVIMED planas nepakeičia papildomų leidėjų teisių.